过敏性鼻炎和慢性鼻炎中的细菌溶解物:机制和临床证据

相关实验视频

Updated: Sep 17, 2025

06:08

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence

Published on: September 22, 2023

2.0K

Xinyu Huang¹, Xu Zhang¹, Zhiqiang Zhang¹

¹Department of Otorhinolaryngology, Head and Neck Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, China.

Science progress

|June 30, 2025

概括

细菌溶解酸 (BLs) 通过调节免疫系统来改善过敏性鼻炎 (AR) 和慢性鼻炎 (CRS). 这些免疫调节剂提高了治疗效率,并减少了上呼吸道炎症疾病的症状严重程度.

科学领域:

免疫学免疫学免疫学
耳鼻喉科耳鼻喉科耳鼻喉科
药理学药理学是指药理学的学科.

背景情况:

过敏性鼻炎 (AR) 和慢性鼻炎 (CRS) 是普遍存在的上呼吸道炎症疾病,具有重大健康和经济影响.
目前对AR和CRS的治疗方法往往无法解决核心病理生理学,需要新的治疗方法.

研究的目的:

批判性地评估细菌溶解物 (BLs) 在AR和CRS中的组成,制造,免疫调节机制和临床应用.
为BLs在管理这些疾病中的临床使用提供一个框架.

主要方法:

按照叙事评论文章评估尺度 (SANRA) 的指导方针对文献进行系统审查.
对研究细菌溶解物 (例如OM-85,Broncho-Vaxom) 对其对免疫路径的影响和AR和CRS的临床结果的研究分析.

主要成果:

细菌溶解酸作为免疫调节剂,激活先天性和适应性免疫,恢复Th1/Th2平衡,减少Th2介导的炎症.
临床证据表明,BL可以改善AR的鼻腔症状得分,并减少CRS的复发和手术需求.
BLs增强粘膜免疫力,并在与标准疗法一起使用时有助于持续的疗效.

结论:

细菌溶解物代表了AR和CRS的有希望的治疗策略,提供了超越传统治疗的免疫调节效益.
BLs增强粘膜免疫防御和临床结果,支持将其纳入上呼吸道炎症疾病的治疗方案.

关键词:

细菌溶解物质的细菌溶解物质过敏性鼻炎过敏性鼻炎慢性鼻鼻炎是什么免疫调节免疫调节免疫调节

相关概念视频

01:16

Drugs Used in Upper Respiratory Disorders: Overview

375

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...

375

01:23

Chronic Pharyngitis

5.2K

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...

5.2K

01:17

Drugs Used in Lower Respiratory Disorders: Overview

618

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...

618

01:19

Antiasthma Drugs: Leukotriene Modifiers

495

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:

495

01:20

Asthma: Pathogenesis and Management

613

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

Allergic Reactions